According to people aware of the development, the National Institute of Health and India's department of biotechnology (DBT) will meet this week as part of a joint vaccine development programme to review the progress made on vaccine candidates for COVID-19, The Economic Times reported on Monday.
Under the Indo-US Vaccine Ando-US Vaccine Action Program, a 35-year-old partnership between the two countries, the parties will now focus on COVID-19 vaccines, and Indian companies with US tie ups will present their R&D of COVID-19 vaccines and their pathways.
DBT has funded five Indian companies for their work on developing a vaccine for SARS-CoV-2, including Bharat Biotech, Zydus Cadila, Gennova Biopharmaceuticals, Biological E and Serum Institute of India.
"We will be presenting along without our US partner on our vaccine progress," said one of the companies that has been invited to make a presentation.
To read more NewsPoints articles, click here.